Literature DB >> 18470639

Spectroscopic methods for the physical characterization and formulation of nonviral gene delivery systems.

Salvador F Ausar1, Sangeeta B Joshi, C Russell Middaugh.   

Abstract

Currently, with the exception of naked DNA formulations, most pharmaceutical preparations of plasmid DNA employ some type of polycationic delivery vector such as synthetic cationic polymers and lipids to enhance delivery. A number of biophysical techniques are readily available for the structural characterization of plasmid DNA within synthetic gene delivery complexes. Here we present applications of ultraviolet (UV) absorption, circular dichroism (CD), infrared (IR), and fluorescence spectroscopies as well as dynamic light scattering to the structural analysis of the oligonucleotide component of nonviral gene delivery vectors. We also illustrate this approach for the investigation of the formulation of lipoplex and polyplex-based gene delivery systems. To summarize such data, we show how the macromolecular complexes can be represented as vectors in a highly dimensional space in which the components of the vector consist of normalized values of experimental parameters measured as a function of different solution conditions such as pH and ionic strength.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18470639     DOI: 10.1007/978-1-60327-248-3_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

Authors:  Nathaniel R Maddux; Sangeeta B Joshi; David B Volkin; John P Ralston; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2011-06-06       Impact factor: 3.534

2.  Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose.

Authors:  María E Aranda-Barradas; Maripaz Márquez; Liliana Quintanar; Jaime Santoyo-Salazar; Armando J Espadas-Álvarez; Daniel Martínez-Fong; Elizabeth García-García
Journal:  Pharmaceutics       Date:  2018-01-03       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.